Back to All Studies

Feline herpesvirus-1 (FHV-1) accounts for approximately 50% of all diagnosed viral upper airway infections and is a major cause of eye infections in cats. Current FHV-1 vaccines are a component of core (recommended) vaccinations. While core vaccines provide satisfactory protection against infection for other common cat viruses, including feline calicivirus (FCV) and feline panleukopenia virus (FPV), protection from FHV-1 is limited and short in duration. To address this problem and reduce the need for multiple core vaccinations, researchers will develop a new three-in-one vaccine that is safe and can provide superior protection from FHV-1, in addition to protection from FCV and FPV. The team hopes their new vaccine will provide long-lasting immunity against all three common cat pathogens.

Study ID
Study Status
Start Date
Grant amount awarded
Grant recipient
Michigan State University
Study country
United States
Gisela Soboll Hussey, DVM, PhD
Study category
Infectious Disease